Boston Trust Walden Corp Sells 1,501 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Boston Trust Walden Corp decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 294,562 shares of the healthcare conglomerate's stock after selling 1,501 shares during the period. UnitedHealth Group accounts for about 1.1% of Boston Trust Walden Corp's holdings, making the stock its 12th biggest position. Boston Trust Walden Corp's holdings in UnitedHealth Group were worth $154,277,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Montz Harcus Wealth Management LLC bought a new stake in UnitedHealth Group in the 1st quarter valued at about $317,000. DB Fitzpatrick & Co Inc raised its position in shares of UnitedHealth Group by 34.3% in the first quarter. DB Fitzpatrick & Co Inc now owns 2,227 shares of the healthcare conglomerate's stock valued at $1,166,000 after purchasing an additional 569 shares during the period. MGO Private Wealth LLC bought a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $209,000. Centennial Wealth Advisory LLC raised its holdings in UnitedHealth Group by 9.7% during the 1st quarter. Centennial Wealth Advisory LLC now owns 906 shares of the healthcare conglomerate's stock valued at $475,000 after acquiring an additional 80 shares during the period. Finally, Davidson Capital Management Inc. raised its holdings in UnitedHealth Group by 3.4% during the 1st quarter. Davidson Capital Management Inc. now owns 6,077 shares of the healthcare conglomerate's stock valued at $3,183,000 after acquiring an additional 201 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In related news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts recently issued reports on UNH shares. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. KeyCorp lowered their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a report on Thursday, May 15th. Finally, Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

UnitedHealth Group Price Performance

UNH stock opened at $306.90 on Thursday. The firm's fifty day moving average is $370.86 and its 200 day moving average is $467.96. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market cap of $278.40 billion, a P/E ratio of 12.85, a P/E/G ratio of 1.45 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business earned $6.91 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.